Psychedelic Alpha Interview Lawyer Matt Zorn On ” How Psychedelics Could Benefit from Trump’s Second Term” | Cannabis Law Report | Where to buy Skittles Moonrock online

Learn where to buy Skittles Moonrock online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

They write in their latest email update

In our latest interview, we speak with lawyer Matt Zorn about the future of psychedelics-related policy in light of the November 2024 U.S. elections.

Aside from being a Partner at Houston-based law firm Yetter Coleman, Zorn has written extensively about the intersection of drugs like cannabis and psychedelics with the law over at On Drugs.

He is no stranger to standing up to the U.S. government to challenge its drug-related laws and their application, teaming up with researchers like Sue Sisley and his colleague Shane Pennington to sue the DEA over its effective rejection of her marijuana for PTSD in veterans study, working with our Editor-at-Large Graham Pechenik to lead the successful challenge against DEA’s plan to schedule five tryptamines, and holding that same agency to task over other matters like access to psilocybin via Right to Try statute and its flouting of FOIA requests. The list goes on… and on.

But now, Zorn is bullish about the potential regulatory openings that an incoming Trump administration might present, he tells our Editor Josh Hardman. Here, he discusses the types of ‘deeper questions’ we might ask about the U.S. system of drug and medicines regulation and how we might begin to reimagine it.